S T A T E O F N E W Y O R K
________________________________________________________________________
2850
2017-2018 Regular Sessions
I N A S S E M B L Y
January 23, 2017
___________
Introduced by M. of A. McDONALD -- read once and referred to the Commit-
tee on Health
AN ACT to amend the insurance law, in relation to directing the New York
state health care quality and cost containment commission to study and
report upon the impact of requiring that certain health insurance
plans provide coverage for treatment of mitochondrial disease
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Section 213 of the insurance law is amended by adding a new
subsection (e) to read as follows:
(E) THE COMMISSION SHALL CAUSE A STUDY TO BE PERFORMED ON THE IMPACT
OF REQUIRING CERTAIN HEALTH INSURANCE PLANS TO PROVIDE COVERAGE FOR
TREATMENT OF MITOCHONDRIAL DISEASE. SUCH STUDY SHALL INCLUDE AN ASSESS-
MENT OF THE IMPACT OF SUCH A REQUIREMENT ON COSTS TO PROVIDERS, THE COST
OF INSURANCE PREMIUMS, AND THE FISCAL IMPACT TO THE STATE. THE COMMIS-
SION SHALL SUBMIT A REPORT OF THE FINDINGS, CONCLUSIONS AND RECOMMENDA-
TION OF SUCH STUDY, ON OR BEFORE NOVEMBER THIRTIETH, TWO THOUSAND EIGH-
TEEN, TO THE GOVERNOR, THE TEMPORARY PRESIDENT OF THE SENATE, THE
SPEAKER OF THE ASSEMBLY, THE CHAIRS OF THE SENATE AND ASSEMBLY INSURANCE
COMMITTEES, AND THE CHAIRS OF THE SENATE AND ASSEMBLY HEALTH COMMITTEES.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00580-01-7